Press release
Lysosomal Storage Diseases Therapeutics Market to Register a CAGR of 10.0% By 2026
Drivers and trends influencing the market : An increasing diagnosis rate due to increasing awareness and financial incentives for orphan drug development to recover R&D costs is the primary factor fueling the growth of the global lysosomal storage diseases therapeutics market. Also, an increasing focus of major biopharmaceutical companies on the research and development of drugs for the treatment of rare diseases is expected to boost the global lysosomal storage diseases therapeutics market during the forecast period. Moreover, the number of treatment options currently in the pipeline is further expected to bolster revenue growth of the global lysosomal storage diseases therapeutics market during the forecast period.
Request to view table of content @ https://www.persistencemarketresearch.com/toc/3145
However, heterogeneity of the disease leading to underdiagnoses of lysosomal storage diseases, lack of treatment options, and high cost of treatment are factors likely to hamper the growth of the global lysosomal storage diseases therapeutics market over the forecast period. Advent of therapies targeting neuropathic manifestations by crossing blood brain barrier (BBB) and therapies that overcome immune response and have better tissue selectivity will define the future landscape of the global lysosomal storage diseases therapeutics market.
Market forecast : The global lysosomal storage diseases therapeutics market has been segmented on the basis of Indication (Gaucher's Diseases, Fabry Diseases, Pompe’s Syndrome, Mucopolysaccharidosis, Others); Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, Others); End User (Hospitals, Clinics); and Region (North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA)).
Request Sample Report@ https://www.persistencemarketresearch.com/samples/3145
The Gaucher's Diseases indication segment is estimated to account for 29.7% revenue share of the global lysosomal storage diseases therapeutics market by 2016 end. The Enzyme Replacement Therapy segment was valued at US$ 4,833.8 Mn in 2015 and is expected to exhibit the highest CAGR of 10.0% over the forecast period to reach US$ 13.58 Bn by 2026 end. The Hospitals end user segment is expected to witness 2.8X increase in revenue over the forecast period and is expected to create absolute $ opportunity of US$ 346.2 Mn in 2017 over 2016.
Among regions, Europe is expected to be the dominant regional market in the global lysosomal storage diseases therapeutics market during the forecast period. The Europe market accounted for the highest revenue share of 34.8% and was valued at US$ 1,773.2 Mn in 2015; and is expected to witness a CAGR of 10.2% during the forecast period. North America is expected to be the second most lucrative market in the global lysosomal storage diseases therapeutics market and is estimated to represent absolute $ opportunity of US$ 159.6 Mn in 2017 over 2016.
Buy Lysosomal Storage Diseases Therapeutics Market Report@ https://www.persistencemarketresearch.com/checkout/3145
Vendor information : Shire PLC, Pfizer, Inc., Sanofi, BioMarin Pharmaceutical Inc., Actelion Ltd., Raptor Pharmaceutical Corp., Protalix Biotherapeutics Inc., and Amicus Therapeutics, Inc. are some of the companies operating in the global lysosomal storage diseases therapeutics market. Top market players are investing in focused R&D initiatives to develop innovative products for the treatment of rare diseases and are looking to drive growth in established markets through strategic partnerships, collaborations, and acquisitions. The report discusses individual strategies of these companies in terms of increasing focus on rare diseases, initiatives to increase awareness, and enhancing distribution base. The report concludes with strategic recommendations for players already present in the market and new players planning to enter the global lysosomal storage diseases therapeutics market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lysosomal Storage Diseases Therapeutics Market to Register a CAGR of 10.0% By 2026 here
News-ID: 826319 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Diseases
Animal Feed Enzymes Market: Rising Cases of Zoonotic Diseases and Food Borne Dis …
Combined share of a few top players in the global animal feed enzymes market is significant enough. This makes the market somewhat consolidated. Novozymes, Azelis Holdings SA, E.l. Du Pont de Nemours and Company, Lesaffre, Rossari Biotech Ltd, BASF SE, Novus International Inc., Associated British Foods plc, Bio-Cat, and Alltech Inc. are to name a few such leading players in the animal feed enzymes market.
Request Sample For More Information…
Sevoflurane, Isoflurane and Desflurane Market Report 2018: Segmentation by Produ …
Global Sevoflurane, Isoflurane and Desflurane market research report provides company profile for Baxter, Lunan Pharmaceutical Group, AbbVie and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the…
Increasing incidence of cancer, orthopaedic diseases, and other chronic diseases …
Future Market Insights delivers key insights on the global teleradiology services market in a new publication titled “Teleradiology Services Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. Teleradiology is the practice of interpretation and analysis of medical images by a radiologist who is not present at the site where the images are generated. This service is utilised by hospitals, emergency care centres, telemedicine companies, and other clinics. Teleradiology services enable…
Rare Diseases Conferences |Europe Rare Diseases Conferences| Orphan Drugs Confer …
4th World Congress on Rare Diseases and Orphan Drugs to promote an interdisciplinary approach to Rare Diseases and Orphan Drugs
We pleased to announce the 4th World Congress on Rare Diseases and Orphan Drugs to be held during June 11-12, 2018 in Dublin, Ireland
Rare Diseases Conference 2018 serve as a bridge between researchers from academia and health care centres enhanced by its well organized scientific sessions, plenary lectures, poster…
Rising Eye Diseases And Chronic Diseases Enhance The Market Growth Of Eye Health …
Worldwide Market Reports added Latest Research Report titled "Global Eye Health Supplements Market by Manufacturers, Regions, Product Type and Application, Forecast to 2022" to its Large Report database.
In this report, the global Eye Health Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Ask for sample copy…
China In Vitro Diagnostics (IVD) Market Research Report 2016 Industry Solutions …
This report studies In Vitro Diagnostics (IVD) in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
Siemens Healthcare
Becton
Dickson and Company
Ortho-Clinical Diagnostics
Johnson and Johnson
Thermo Fisher Scientific
Bio-Rad Laboratories
Sysmex Corporation
bioMrieux
Beckman Coulter
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Hematology
Others
Split by Application, this report focuses…
